← FDA Drug Approvals (Drugs@FDA)

OZANIMOD

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2026-07-13

Drug application

FDA Application #
ANDA219450
Application type
Abbreviated New Drug Application (Generic)
Brand name
OZANIMOD
Generic name
Ozanimod
Active ingredients
OZANIMOD
Dosage form
CAPSULE
Route
—
Marketing status
None (Tentative Approval)
Sponsor
APOTEX INC
First approval
2026-07-13

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown